Hemostasis, Surgical

• 

  Subject Areas on Research

  • A randomized trial of vascular hemostasis techniques to reduce femoral vascular complications after coronary intervention. 
  • An endoluminal method of hemorrhage control and repair of ruptured abdominal aortic aneurysms. 
  • Application of energy-based technologies and topical hemostatic agents in the management of surgical hemostasis. 
  • Bedside Tracheostomy on Pediatric ICU Subjects Supported by Extracorporeal Membrane Oxygenation. 
  • Biological and pharmacological aspects of perioperative hemorrhagic complications associated with oral platelet-directed antithrombotic agents. Focus on isolated coronary artery bypass grafting and oral irreversible P2Y(12) receptor antagonists. 
  • Bivalirudin: a review of the pharmacology and clinical application. 
  • Bovine thrombin: history, use, and risk in the surgical patient. 
  • Closure devices and vascular complications among percutaneous coronary intervention patients receiving enoxaparin, glycoprotein IIb/IIIa inhibitors, and clopidogrel. 
  • Comparison Between Radial Approach and Femoral Approach With Vascular Closure Devices on the Occurrence of Access-Site Complications and Periprocedural Bleeding After Percutaneous Coronary Procedures: A Systematic Review and Meta-Analysis. 
  • Ectopic pregnancy: role of laparoscopic treatment. 
  • Evaluation and Comparison of Contemporary Energy-Based Surgical Vessel Sealing Devices. 
  • Evaluation of the topical hemostatic efficacy and safety of TISSEEL VH S/D fibrin sealant compared with currently licensed TISSEEL VH in patients undergoing cardiac surgery: a phase 3, randomized, double-blind clinical study. 
  • Fatal and nonfatal hemorrhagic complications of living kidney donation. 
  • Fibrin sealant improves hemostasis in peripheral vascular surgery: a randomized prospective trial. 
  • Haemodilution-induced profibrinolytic state is mitigated by fresh-frozen plasma: implications for early haemostatic intervention in massive haemorrhage. 
  • Hand-assisted laparoscopic partial nephrectomy without hilar vascular clamping using a saline-cooled, high-density monopolar radiofrequency device. 
  • Hemostasis using a bipolar sealer in primary unilateral total knee arthroplasty. 
  • Hemostatic agent and concomitant abdominal abscess. 
  • Immunologic impact and clinical outcomes after surgical exposure to bovine thrombin. 
  • International normalized ratio. 
  • Intraoperative use of low-dose recombinant activated factor VII during thoracic aortic operations. 
  • Invited letter concerning: the promotional effect of bone wax on experimental Staphylococcus aureus osteomyelitis and postoperative mediastinitis--a comparison of two electrocautery techniques on presternal soft tissues. 
  • Management of surgical hemostasis: systemic agents. 
  • Management of surgical hemostasis: topical agents. 
  • New paradigms in cardiovascular medicine: emerging technologies and practices: perioperative genomics. 
  • Overview of clinical efficacy and safety of pharmacologic strategies for blood conservation. 
  • Patterns of use and comparative effectiveness of bleeding avoidance strategies in men and women following percutaneous coronary interventions: an observational study from the National Cardiovascular Data Registry. 
  • Phase 2, randomized, double-blind, placebo-controlled, multicenter clinical evaluation of recombinant human thrombin in multiple surgical indications. 
  • PlasmaKinetic bipolar vessel sealing: burst pressures and thermal spread in an animal model. 
  • Prohemostatic agents to prevent perioperative blood loss. 
  • Prohemostatic treatment in cardiac surgery. 
  • Prophylactic correction of the international normalized ratio in neurosurgery: a brief review of a brief literature. 
  • Prospective, multicenter, randomized, controlled trial evaluating the performance of a novel combination powder vs hemostatic matrix in cardiothoracic operations. 
  • Quantifying the learning curve in the use of a novel vascular closure device: an analysis of the NCDR (National Cardiovascular Data Registry) CathPCI registry. 
  • Randomized evaluation of fibrinogen vs placebo in complex cardiovascular surgery (REPLACE): a double-blind phase III study of haemostatic therapy. 
  • Recent clinical and investigational applications of fibrin sealant in selected surgical specialties. 
  • Recombinant activated factor VII and the anaesthetist. 
  • Recombinant human antithrombin III restores heparin responsiveness and decreases activation of coagulation in heparin-resistant patients during cardiopulmonary bypass. 
  • Reductions in blood loss with a bipolar sealer in total hip arthroplasty. 
  • Reductions in blood loss with use of a bipolar sealer for hemostasis in primary total knee arthroplasty. 
  • Relative purity of thrombin-based hemostatic agents used in surgery. 
  • Review of the biology of bleeding and clotting in the surgical patient. 
  • Transradial coronary stenting: comparison with femoral access closed with an arterial suture device. 
  • What is the evidence for platelet transfusion in perioperative settings? 
  • Wound hematoma: prophylaxis with topical thrombin. 
• 

  Keywords of People

  • Ghadimi, Kamrouz, Associate Professor of Anesthesiology, Anesthesiology, Cardiothoracic
  • Hoffman, Maureane, Professor of Pathology, Immunology
  • Preminger, Glenn Michael, James F. Glenn, M.D. Distinguished Professor of Urology, Surgery